Nova Leap Health Corp. NVLPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.60M | 32.23M | 31.47M | 29.96M | 28.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.60M | 32.23M | 31.47M | 29.96M | 28.11M |
| Cost of Revenue | 20.19M | 19.38M | 18.98M | 18.13M | 17.11M |
| Gross Profit | 13.41M | 12.85M | 12.48M | 11.84M | 11.00M |
| SG&A Expenses | 10.93M | 10.74M | 10.54M | 9.98M | 9.44M |
| Depreciation & Amortization | 755.00K | 785.10K | 833.10K | 787.50K | 700.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.87M | 30.90M | 30.36M | 28.90M | 27.25M |
| Operating Income | 1.73M | 1.32M | 1.11M | 1.07M | 854.90K |
| Income Before Tax | 1.86M | 399.60K | -132.00K | 1.01M | 278.10K |
| Income Tax Expenses | 513.90K | 186.50K | 57.80K | 262.80K | 162.00K |
| Earnings from Continuing Operations | 1.35 | 0.21 | -0.19 | 0.75 | 0.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.35M | 213.10K | -189.80K | 750.20K | 116.10K |
| EBIT | 1.73M | 1.32M | 1.11M | 1.07M | 854.90K |
| EBITDA | 2.41M | 2.04M | 1.87M | 1.77M | 1.48M |
| EPS Basic | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |
| EPS Diluted | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 352.57M | 352.57M | 352.57M | 344.98M | 343.88M |
| Average Diluted Shares Outstanding | 354.85M | 353.90M | 353.21M | 347.45M | 345.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |